Evidence map›Paper›PMID 34646776›Full record

ArticleFrontiers in oncology2021

Radiotherapy Response Assessment of Multiple Myeloma: A Dual-Energy CT Approach With Virtual Non-Calcium Images.

Philipp Fervers, Erkan Celik, Grischa Bratke, David Maintz, Christian Baues, Simon Ruffing, Philip Pollman-Schweckhorst, Jonathan Kottlors, Simon Lennartz, Nils Große Hokamp

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Dual-Energy CT in Oncologic Imaging.Tomography (Ann Arbor, Mich.) · 2024
    Review
  6. Imaging of Multiple Myeloma: Present and Future.Journal of clinical medicine · 2024
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Philipp FerversDepartment of Radiology, University Hospital of Cologne, Cologne, Germany.
Erkan CelikDepartment of Radiology, University Hospital of Cologne, Cologne, Germany.
Grischa BratkeDepartment of Radiology, University Hospital of Cologne, Cologne, Germany.
David MaintzDepartment of Radiology, University Hospital of Cologne, Cologne, Germany.
Christian BauesDepartment of Radiotherapy and Cyberknife Center, University Hospital of Cologne, Cologne, Germany.
Simon RuffingDepartment of Radiotherapy and Cyberknife Center, University Hospital of Cologne, Cologne, Germany.
Philip Pollman-SchweckhorstChair in Marketing Science and Analytics, University of Cologne, Cologne, Germany.
Jonathan KottlorsDepartment of Radiology, University Hospital of Cologne, Cologne, Germany.
Simon LennartzDepartment of Radiology, University Hospital of Cologne, Cologne, Germany.
Nils Große HokampDepartment of Radiology, University Hospital of Cologne, Cologne, Germany.
University Hospital Cologne · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLife expectancy of patients with multiple myeloma (MM) has increased over the past decades, underlining the importance of local tumor control and avoidance of dose-dependent side effects of palliative radiotherapy (RT). Virtual noncalcium (VNCa) imaging from dual-energy computed tomography (DECT) has been suggested to estimate cellularity and metabolic activity of lytic bone lesions (LBLs) in MM.

objectiveTo explore the feasibility of RT response monitoring with DECT-derived VNCa attenuation measurements in MM.

methodsThirty-three patients with 85 LBLs that had been irradiated and 85 paired non-irradiated LBLs from the same patients were included in this retrospective study. Irradiated and non-irradiated LBLs were measured by circular regions of interest (ROIs) on conventional and VNCa images in a total of 216 follow-up measurements (48 before and 168 after RT). Follow-ups were rated as therapy response, stable disease, or local progression according to the MD Anderson criteria. Receiver operating characteristic (ROC) analysis was performed to discriminate irradiated

resultsAttenuation of LBLs decreased after RT depending on the time that had passed after irradiation [absolute thresholds for identification of irradiated LBLs 30.5-70.0 HU [best area under the curve [AUC] 0.75 (0.59-0.91)] and -77.0 to -22.5 HU [best AUC 0.85 (0.65-1.00)]/-50% and -117% to -167% proportional change of attenuation on conventional and VNCa images, respectively]. VNCa CT was significantly superior for identification of RT effects in LBLs with higher calcium content [best VNCa AUC 0.96 (0.91-1.00), best conventional CT AUC 0.64 (0.45-0.83)]. Thresholds for early identification of local irradiation failure were >20.5 HU on conventional CT [AUC 0.78 (0.68-0.88)] and >-27 HU on VNCa CT [AUC 0.83 (0.70-0.96)].

conclusionTherapy response of LBLs after RT can be monitored by VNCa imaging based on regular myeloma scans, which yields potential for optimizing the lesion-specific radiation dose for local tumor control. Decreasing attenuation indicates RT response, while above threshold attenuation of LBLs precedes local irradiation failure.

Indexed as

computed tomographydual-energy acquisitionirradiation responsemultiple myelomaradiation oncologyvirtual noncalcium

Identifiers

PMID34646776
PMCPMC8504158
OpenAlexW3202350830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.